construction release_alert

The Scholars Team is working with OIT to resolve some issues with the Scholars search index

cancel

ML44399, "A multicenter trial to identify optimal atezolizumab biomarkers in the setting of recurrent gliobastoma. The MOAB Trial.

Clinical Trial Grant

Duke Scholars

Principal Investigator Mustafa Khasraw Neurosurgery

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

October 5, 2023

End Date

October 31, 2027

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

October 5, 2023

End Date

October 31, 2027